Teva ADR (NYSE: TEVA ) reported third quarter EPS of $0.69, $0.03 better than the analyst estimate of $0.66. Revenue for the quarter came in at $4.33B versus the consensus estimate of $4.14B.
Teva ADR's stock price closed at $18.77. It is up 7.69% in the last 3 months and up 107.63% in the last 12 months.
Teva ADR saw 2 positive EPS revisions and 3 negative EPS revisions in the last 90 days. See Teva ADR's stock price’s past reactions to earnings here.
According to InvestingPro, Teva ADR's Financial Health score is "great performance".
Check out Teva ADR's recent earnings performance , and Teva ADR's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Source: Investing.com